azacitidine has been researched along with Hyperhomocysteinemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Behera, J; Tyagi, N; Tyagi, SC | 1 |
Bratcher, AP; Givvimani, S; James, D; Kundu, S; Metreveli, N; Narayanan, N; Pushpakumar, SB; Tyagi, SC | 1 |
Gao, SL; Gao, SS; Guo, RW; Li, L; Zhai, XJ | 1 |
3 other study(ies) available for azacitidine and Hyperhomocysteinemia
Article | Year |
---|---|
Hyperhomocysteinemia induced endothelial progenitor cells dysfunction through hyper-methylation of CBS promoter.
Topics: Angiogenesis Inducing Agents; Animals; Azacitidine; Bone and Bones; Bone Marrow Cells; Cell Differentiation; Cystathionine beta-Synthase; DNA Methylation; Endothelial Progenitor Cells; Hyperhomocysteinemia; Methionine; Methyltransferases; Mice; Promoter Regions, Genetic; Regional Blood Flow | 2019 |
Epigenetic regulation of aortic remodeling in hyperhomocysteinemia.
Topics: Acetylcholine; Adenosylhomocysteinase; Animals; Aorta; Azacitidine; Collagen; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Endothelium, Vascular; Epigenesis, Genetic; Extracellular Matrix Proteins; Gene Expression Regulation, Enzymologic; Homocystinuria; Hyperhomocysteinemia; Hypertension; Male; Matrix Metalloproteinase 9; Methylenetetrahydrofolate Reductase (NADPH2); Mice; Mice, Inbred C57BL; Mice, Knockout; Nitroprusside; Phenylephrine; Tissue Inhibitor of Metalloproteinase-1; Ultrasonography; Vascular Resistance | 2014 |
[Effects and related mechanism of 5-aza-2'-deoxycytidine on endothelial function in rats with hyperhomocysteinemia].
Topics: Acetylcholine; Amidohydrolases; Animals; Azacitidine; Decitabine; Diet; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Endothelium, Vascular; Hyperhomocysteinemia; Male; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Synthase Type III; Random Allocation; Rats; Rats, Sprague-Dawley | 2016 |